Skip to main content

Mixed close ahead of earnings

The markets closed mixed with the Dow slipping 12 points to 25,283 ahead of earnings season. Nasdaq gained 20 points to 7157.


On the upside


Novo Nordisk made an unsolicited $3.1 billion offer to acquire Ablynx (Nasdaq: ABLX).


The Food and Drug Administration approved Nevro's (NYSE: NVRO) next generation Senza II Spinal Cord Stimulation System.


Tandem Diabetes Care (Nasdaq: TNDM) successfully completed the first pilot study using a hybrid closed loop system featuring its t:slim X2 Insulin Pump.


On the downside


Oxford Immunotec Global (Nasdaq: OXFD) reported preliminary fourth quarter revenue that fell short of previous guidance.


Natus Medical (Nasdaq: BABY) reported preliminary fourth quarter revenue that was lower than expected.


Invitae (NYSE: NVTA) forecast disappointing 2018 revenue.


In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 2 on the NYSE while advancers were on par with decliners on Nasdaq. The broader S&P 500 rose 4 points to 2,747. Bitcoin gained $117 to $14,774.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.